SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 15, 2026

ANIP

ANI PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

The insider sales are too small to carry informational content. Monitor for any upcoming earnings release or material corporate events that could provide context, but no immediate trading action is warranted based on this cluster alone.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$83.00
T+0 close · Jun 15, 2026 · via day close
Latest settled
−13.90%
T+60 · $71.46
Vs SPY
−14.90%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 16 $83.00entry
  2. T+1 · 5mo ago −2.99%α −1.74% · $80.52
  3. T+5 · 5mo ago −0.07%α +2.16% · $82.94
  4. T+20 · 4mo ago −2.95%α −3.15% · $80.55
  5. T+60 · 2mo ago −13.90%α −14.90% · $71.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three ANIP insiders (Director, CFO, and General Counsel) sold a total of $468K in open-market transactions over a 7-day window. The total represents just 0.026% of the company's $1.8B market cap, a trivial amount that is consistent with routine portfolio diversification and not indicative of material negative sentiment.

Key Financial Metrics

Direction
selling
Total Value
$468.0K
Insiders
3

Key Facts

  • Total insider sales of $468K over 7 days (June 5–12, 2026)
  • Three insiders sold: Director Thomas Haughey ($162K), CFO Stephen Carey ($265K), General Counsel Meredith Cook ($41K)
  • Sales represent 0.026% of ANIP's $1.8B market cap, well below the 0.1% materiality threshold
  • All transactions were open-market sales (code S); no 10b5-1 plan disclosure in the filing

Financial Impact

Negligible, $468K is 0.026% of market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if management perceives headwinds, but current volume is routine

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIP-1781563496396

Track record

34 reports on ANIP

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +8.88% at T+60 after the Apr 8, 2026 report. 8 of 12 went positive at some point.

Filters
  1. Nov 18, 20263d ago Insider Cluster Neutral 2/10 Entry $69.13 Now $68.55 −0.84% settles Dec 18
  2. Nov 16, 20265d ago 144 Neutral 2/10 Entry $69.99 Now $68.55 −2.06% settles Dec 16
  3. Nov 16, 20266d ago 8-K Neutral 3/10 Entry $70.89 Now $68.55 −3.30% settles Dec 15
  4. Nov 9, 202612d ago Institutional Cluster Mixed 3/10 Entry $67.79 Now $68.55 +1.12% settles Dec 8
  5. Nov 5, 202616d ago 8-K Neutral 5/10 Entry $67.41 Now $68.55 +1.69% settles Dec 7
  6. Nov 5, 202617d ago 8-K Bullish 6/10 No price data
  7. Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
  8. Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
  9. Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
  10. Oct 29, 202623d ago 144 Neutral 2/10 Entry $72.00 Now $68.55 −4.79% settles Nov 30
Showing 10 of 34

US Market Status

Market Closed · Opens Mon (25h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026